Enhancing Attention and Wellbeing Using Digital Therapeutics

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60-99
SponsorUniversity of California, San Francisco

About this trial

The goals of the proposed research are to first determine the minimal and/or optimal dose of a digital intervention required for cognitive enhancement, and then to examine the impact of several potential moderators of treatment effects (i.e., cognitive decline, AD polygenic hazard score, cardiovascular risk, and race/ethnicity). This knowledge gained from his high-impact study with transform the field of cognitive interventions, paving the way for a precision medicine model for cognitive enhancing interventions that improve quality of life for older adults and individuals with cognitive deficits at risk of developing dementia.

Eligibility criteria

Qualifiers

60+ years old (adult)

English language fluency

owning a smartphone or tablet

Disqualifiers

Under 60 years old (minor)

Trial design

Treatments tested in this trial

  • MediTrain
  • Worder

Treatment groups

4,000 Participants
are divided into 5 treatment groups

Sponsors and collaborators

University of California, San Francisco

Lead sponsor

National Institute on Aging (NIA)

Collaborator